KKR.NYSEKkr & CO INC

Form 4: KKR Entities Divest Over 2 Million Shares of BrightSpring Health Services in Secondary Offering

Sentiment:

Insider Transaction Report


KKR Group Partnership L.P. and affiliated entities, significant shareholders and directors of BrightSpring Health Services, Inc., reported the sale of 2.1 million common shares as part of a secondary public offering's over-allotment option.

Capital raiseThe document details a secondary public offering where KKR entities sold 2,100,000 shares of BrightSpring Health Services common stock.This represents a capital raise for the selling shareholders (KKR entities) as they monetize a portion of their investment.

Summary

  • KKR Group Partnership L.P. and several related KKR entities, including KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, and George R. Roberts, reported a disposition of BrightSpring Health Services, Inc. common stock.
  • The transaction involved the sale of 2,100,000 shares of common stock on June 24, 2025.
  • The shares were sold at a price of $21.1519 per share, which reflects the secondary public offering price of $21.75 less underwriting discounts and commissions of $0.598125 per share.
  • This sale was in connection with the underwriters' exercise of their over-allotment option related to a secondary offering that closed on June 24, 2025.
  • Following this transaction, KKR Group Partnership L.P. and its affiliates beneficially own 77,096,337 shares of BrightSpring Health Services, Inc. common stock.
  • The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest.
  • Due to EDGAR system limitations, certain affiliates filed a separate Form 4, as noted in Exhibit 99.1.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a large insider sale by a significant shareholder and director, which can sometimes be interpreted as a lack of confidence. However, it's mitigated by the fact that it's part of a secondary offering, a common and expected private equity exit strategy, rather than an unexpected open-market sale.

Positives

  • The secondary offering, which included this sale, can increase the public float of BrightSpring Health Services' stock, potentially improving its liquidity and market accessibility for other investors.

Negatives

  • A significant sale by a major insider and 10% owner like KKR could be perceived by the market as a reduction in confidence or a strategic exit, potentially putting downward pressure on the stock price.
  • The sale price of $21.1519 per share is lower than the stated secondary public offering price of $21.75, due to underwriting discounts and commissions.

Risks

  • The large volume of shares sold by a major institutional investor could lead to increased selling pressure on BrightSpring Health Services' stock in the short term.
  • Investor sentiment might be negatively impacted by a significant insider sale, potentially leading to a re-evaluation of the company's prospects by some market participants.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding BrightSpring Health Services' future performance or strategic direction. It solely reports an insider transaction.

Industry Context

This filing reflects a liquidity event for a major private equity investor (KKR) in a healthcare services company. Such secondary offerings are common strategies for private equity firms to monetize their investments in portfolio companies after an IPO, allowing them to return capital to their limited partners.

Related Party Transactions

  • The sale of shares by KKR Group Partnership L.P. and its affiliates, who are 10% owners and have director representation on BrightSpring Health Services' board, constitutes a related party transaction.

Stakeholder Impact

  • Shareholders: The increased public float from the secondary offering may improve liquidity, but the large insider sale could also create selling pressure or raise questions about insider confidence.
  • KKR Entities: This transaction represents a partial monetization of their investment in BrightSpring Health Services, providing liquidity to their funds.

Key Dates

DateDescription
06/24/2025Date of the reported transaction (sale of common stock) and closing of the secondary offering's over-allotment option.
06/26/2025Date the Form 4 was signed and filed.

Keywords

BrightSpring Health Services, BTSG, KKR, Form 4, Insider Sale, Secondary Offering, Share Disposition, Beneficial Ownership, Private Equity Exit, Healthcare Services

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.